DLQIX
Price
$15.22
Change
-$0.09 (-0.59%)
Updated
Jul 13 closing price
Net Assets
137.24M
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

DLQIX vs VSTSX

DLQIX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
DLQIX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLQIX is a Buy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. DLQIX (137M). VSTSX pays higher dividends than DLQIX: VSTSX (1.07) vs DLQIX (0.53). DLQIX was incepted earlier than VSTSX: DLQIX (29 years) vs VSTSX (10 years). DLQIX (0.88) is less costly to investors than VSTSX (0.01). DLQIX is a more actively managed with annual turnover of: 38.87 vs. VSTSX (3.00). DLQIX has a lower initial minimum investment than VSTSX: DLQIX (1000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. DLQIX (-2.99). VSTSX return over 5 years is better than : 66.56 vs. DLQIX (-47.97).
DLQIXVSTSXDLQIX / VSTSX
Total Expense Ratio0.750.017,500%
Annual Report Gross Expense Ratio0.880.018,800%
Fund Existence29 years10 years-
Gain YTD4.72011.20542%
Front LoadN/AN/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets137M2.3T0%
Annual Yield % from dividends0.531.0749%
Returns for 1 year-2.9921.48-14%
Returns for 3 years-24.4467.06-36%
Returns for 5 years-47.9766.56-72%
Returns for 10 years-7.63239.53-3%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I